Skip to main content
PMC home page
Springer logoLink to Springer
. 2015 Jun 24;152(2):253. doi: 10.1007/s10549-015-3478-0

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

T J A Dekker 1,2, S ter Borg 3, G K J Hooijer 3, S L Meijer 3, J Wesseling 4, J E Boers 5, E Schuuring 6, J Bart 5,6, J van Gorp 7, P Bult 8, S A Riemersma 9, C H M van Deurzen 10, H F B M Sleddens 10, W E Mesker 2, J R Kroep 1, V T H B M Smit 11, M J van de Vijver 3,✉
PMCID: PMC4643603  PMID: 26105796

Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-015-3444-x

Unfortunately, in the original publication of the article, the abstract has an oversight. The authors regret for this error.

The sentence in the abstract that reads as “Sensitivity and specificity of individual laboratories for testing estrogen receptor expression were high, with an overall sensitivity of 99.7 and 95.4 %, respectively”, should read as “Sensitivity and specificity of individual laboratories for testing estrogen receptor expression were high, with an overall sensitivity and specificity of 99.7 and 95.4 %, respectively”.

Footnotes

The online version of the original article can be found under doi:10.1007/s10549-015-3444-x.

Contributor Information

T. J. A. Dekker, Email: T.J.A.Dekker@lumc.nl

M. J. van de Vijver, Email: m.j.vandevijver@amc.uva.nl

Articles from Breast Cancer Research and Treatment are provided here courtesy of Springer

RESOURCES